Correlation Between Foghorn Therapeutics and Zivo Bioscience

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Foghorn Therapeutics and Zivo Bioscience at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Foghorn Therapeutics and Zivo Bioscience into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Foghorn Therapeutics and Zivo Bioscience, you can compare the effects of market volatilities on Foghorn Therapeutics and Zivo Bioscience and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Foghorn Therapeutics with a short position of Zivo Bioscience. Check out your portfolio center. Please also check ongoing floating volatility patterns of Foghorn Therapeutics and Zivo Bioscience.

Diversification Opportunities for Foghorn Therapeutics and Zivo Bioscience

0.27
  Correlation Coefficient

Modest diversification

The 3 months correlation between Foghorn and Zivo is 0.27. Overlapping area represents the amount of risk that can be diversified away by holding Foghorn Therapeutics and Zivo Bioscience in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zivo Bioscience and Foghorn Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Foghorn Therapeutics are associated (or correlated) with Zivo Bioscience. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zivo Bioscience has no effect on the direction of Foghorn Therapeutics i.e., Foghorn Therapeutics and Zivo Bioscience go up and down completely randomly.

Pair Corralation between Foghorn Therapeutics and Zivo Bioscience

Given the investment horizon of 90 days Foghorn Therapeutics is expected to generate 1.27 times more return on investment than Zivo Bioscience. However, Foghorn Therapeutics is 1.27 times more volatile than Zivo Bioscience. It trades about 0.04 of its potential returns per unit of risk. Zivo Bioscience is currently generating about -0.03 per unit of risk. If you would invest  657.00  in Foghorn Therapeutics on August 27, 2024 and sell it today you would earn a total of  127.00  from holding Foghorn Therapeutics or generate 19.33% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy31.85%
ValuesDaily Returns

Foghorn Therapeutics  vs.  Zivo Bioscience

 Performance 
       Timeline  
Foghorn Therapeutics 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Very Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Foghorn Therapeutics are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Foghorn Therapeutics may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Zivo Bioscience 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Zivo Bioscience has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Zivo Bioscience is not utilizing all of its potentials. The newest stock price disarray, may contribute to short-term losses for the investors.

Foghorn Therapeutics and Zivo Bioscience Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Foghorn Therapeutics and Zivo Bioscience

The main advantage of trading using opposite Foghorn Therapeutics and Zivo Bioscience positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Foghorn Therapeutics position performs unexpectedly, Zivo Bioscience can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zivo Bioscience will offset losses from the drop in Zivo Bioscience's long position.
The idea behind Foghorn Therapeutics and Zivo Bioscience pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Other Complementary Tools

Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators